Real-Time MV/kV Image Guided Radiation Therapy

Prostate Cancer Clinical Trial

Official title:

Real-Time MV/kV Image Guided Radiation Therapy

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01260909
• Other study ID #: PROS0038
• Secondary ID: SU-12132010-7282
• Status: Withdrawn
• Phase: N/A
• First received: December 14, 2010
• Last updated: November 29, 2017
• Start date: January 2014
• Est. completion date: January 2015

Study information

• Verified date: November 2017
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In current radiation therapy, imaging (typically, cone beam CT imaging or two orthogonal X-ray projection imaging) is done for patient setup before radiation dose delivery. Dose delivery typically takes 2 to 5 minutes depending on the delivery technique used for treatment. A tumor target may change its position during the dose delivery process. The goal of this project is develop a real-time imaging strategy to monitor the tumor position during dose delivery and evaluate its potential clinical impact.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: January 2015
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• The study population will be drawn from available patient population that will be treated using IMRT/VMAT. The Stanford population of IMRT/VMAT will be taken as roughly representative of prospective IMRT patients and will not be subdivided by any additional characteristics.

Exclusion Criteria:

• The study population will be drawn from available patient population that will be treated using IMRT/VMAT. The Stanford population of IMRT/VMAT will be taken as roughly representative of prospective IMRT patients and will not be subdivided by any additional characteristics.

Related Conditions & MeSH terms

• Prostate Cancer

Intervention

Device:
• Real-time kV/MV Prostate Imaging
The kV images will be acquired using onboard kV X-Ray imaging system existing in the clinical linear accelerator (LINAC).

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
Stanford University	National Cancer Institute (NCI), National Institutes of Health (NIH)

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To verify improved tumor targeting accuracy using IMRT (intensity modulated radiation therapy) and VMAT (volumetric modulated radiation therapy)		2 years